Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Private certification, insurer evaluation and peer-reviewed research step up.
INOVIO (NASDAQ: INO) announced that it has completed the rolling submission of its Biologics License Application (BLA) for ...
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring ...
Representatives from companies such as Sanofi and Forge Biologics point to the potential for PreCheck to drive activation of ...
As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback